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Glucocorticosteroids reduce the production of
in￿ ammatory mediators but this effect may de-
pend on the stimulus. We have compared the time
course of the effect of dexamethasone on the
thromboxane B2 (TXB2) release induced by cyto-
kine stimulation and zymosan in guinea-pig al-
veolar macrophages. Interleukin-1b (IL-1b),
tumour necrosis factor-a (TNF-a) and opsonized
zymosan (OZ), all stimulate TXB2 release. High
concentrations of dexamethasone (1±10 mM) in-
hibit the TXB2 production induced by both cyto-
kines and OZ, but the time course of this
response is different. Four hours of incubation
with dexamethasone reduce the basal TXB2 re-
lease and that induced by IL-1b and TNF-a, but do
not modify the TXB2 release induced by OZ.
However, this stimulus was reduced after 24 h
incubation. Our results suggest that the anti-
in￿ ammatory activity of glucocorticosteroids
shows some dependence on stimulus and, there-
fore, may have more than one mechanism in-
volved.
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Introduction
Alveolar macrophages are distributed widely in
the airways and lung parenchyma. They release a
range of mediators including those derived from
arachidonic acid such as thromboxane A2
(TXA2), which is rapidly converted to its stable
metabolite thromboxane B2 (TXB2), and proin-
￿ammatory cytokines such as interleukin 1b (IL-
1b) and tumour necrosis factor a (TNF-a).1
These cytokines act on other in￿ammatory cells
and also exert an autocrine control of macro-
phages.2 The preincubation with IL-1b or TNF-a
induces the production of metabolites of arachi-
donic acid in peritoneal macrophages,3 mono-
cytes,4 neutrophils,5 endothelial cells6 and
synovial cells.7 The action of these cytokines is
probably due to an increase in the activity of
enzymes involved in the activation of membrane
phospholipids. In some in￿ammatory cells, IL-1b
and TNF-a induce the synthesis of the cytosolic
and secreted phospholipase A2 group II (cPLA2
and sPLA2 group II)8,9 and the inducible form
of cyclooxygenase (COX-2). 10- 12 It has recently
been described that some of the pro-in￿amma-
tory effects induced by IL-1b and TNF-a are
mediated by the activation of the transcription
factors, activating protein-1 (AP-1) and nuclear
factor kappa B (NFkB).13 In some in￿ammatory
cells, phagocytosis of opsonized zymosan (OZ)
stimulates the release of eicosanoids and this
effect seems to be independent of the produc-
tion of speci￿c forms of PLA2 and COX.
Glucocorticosteroids are an effective treat-
ment for controlling in￿ammatory diseases.
Their biological effects are produced in part by
the alteration of gene expression in their target
cells. By binding to the DNA, glucocortico-
steroids modulate the synthesis of proteins
regulating the production and the effects of
in￿ammatory mediators.14 One system inhibited
by glucocorticosteroids seems to be the reduc-
tion of eicosanoid release. Inhibition of prosta-
glandin synthesis by in vitro glucocortico-
steroids in monocytes,15 macrophages16,17 and
endothelial cells18 has been reported. To explain
this inhibitory effect, two different mechanisms
have been proposed: (1) the induction of the
synthesis of lipocortins, which act as antago-
nists of PLA2
19,20 and (2) the direct inhibition of
the synthesis and release of PLA2
21 and COX-
222,23 induced by cytokines. In some animal
models, the production of lipocortins has also
been proposed as the mechanism by which
glucocorticoids inhibit the eicosanoid release
induced by OZ.19 However, whether this me-
chanism of glucocorticosteroid action is the
same for all systems has not been investigated.
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time course and the concentration response to
dexamethasone on the TXB2 release induced by
OZ and the proin￿ammatory cytokines IL-1b
and TNF-a.
Materials and Methods
Materials
Zymosan A, dexamethasone, TXB2, antiserum to
TXB2, IL-1b, TNF-a, trizma base, albumin bovine
(BSA), dextran and activated charcoal were
obtained from Sigma Chemical Co. (St Louis,
MO); Dulbecco’s Modi￿ed Eagle’s Medium
(DMEM) and phosphate-buffered saline (PBS)
from GIBCO(Grand Island, NY); May-Gru ¨nwald-
Giemsa from Merck (Germany); [3H]TXB2
(120 Ci/mmol) from Amersham International
(UK); scintillation cocktail from (Scharlau,
Spain) and 24-well culture plates from Corning
(NY). The biological activities of IL-1b and TNF-
a were 5 3 107 U/mg and 2 3 107 U/mg, re-
spectively. Zymosan was opsonized by incuba-
tion with pooled guinea pig serum for 30 min at
378 C, and used after centrifugation at 1800 rpm
room temperature for 3 min and washing in PBS
four times.
Methods
Alveolar m acrophage isolation and culture
Male Dunkin-Hartley guinea pigs weighing
about 400 g were used. The guinea pigs were
anaesthetized by intraperitoneal injection of
sodium thiopental (50 mg/kg) (Braun Medical
SA, Spain). The trachea was cannulated and
the heart and lungs were removed en bloc.
The lungs were lavaged in 9 ml aliquots, for a
total volume of 36 ml sterile PBS and gently
massaged with each infusate in order to
maximize the cell yield. The cell suspension
was washed twice by centrifugation at
1000 rpm at room temperature for 10 min,
and further dissolution in 20 ml of sterile PBS.
The total cell count was determined on a grid
haemocytometer. A typical lavage yielded
0·8- 1·8 3 107 cells comprised of 90±95%
macrophages as con￿rmed by the May-Gru ¨n-
wald-Giemsa dye. Afterwards, alveolar macro-
phages were resuspended in DMEM at a
density of 3 3 105 cells/ml, placed in the 24-
well plates (1 ml/well) and incubated at 378 C,
in a humidi￿ed 95% air/5% CO2 atmosphere,
for 1 h, to allow adherence. Then, the cells
were washed three times with fresh DMEM
and the drug exposure was performed. Gui-
nea-pig alveolar macrophages were exposed to
OZ (10±1000 mg/ml PBS), IL-1b (0.1±10 ng/ml
PBS 0.1% BSA) or TNF-a (0.1±10 ng/ml PBS
0.1% BSA) for 1 h or 4 h. After this time, the
supernatant was harvested and added to 0.5M
TRIS HCl pH 7.4, in a ratio 9:1, and stored at
- 208 C for the later analysis of TXB2. Each
experiment was made in duplicate. The effects
of all solvents used were tested. None affected
the cellular response.
To study the effect of glucocorticosteroids on
the TXB2 release induced by OZ, macrophages
were incubated during 4 h or 24 h in the
presence or absence of dexamethasone (0.1±
100 mM PBS 0.01% ethanol). Following this
incubation, the cells were washed twice with
fresh DMEM and challenged to OZ (1 mg/ml
PBS) for 1 h. In further experiments, macro-
phages were incubated with several concentra-
tions of OZ (10±1000 mg/ml) in the presence
or absence of a ￿xed high concentration of
dexamethasone (10 mM) for 4 h.
To analyse the effect of glucorticosteroids on
the TXB2 release induced by cytokines, macro-
phages were incubated during 4 h with a ￿xed
concentration of IL-1b (1 ng/ml) or TNF-a
(3 ng/ml) and several concentrations of dexa-
methasone (0.1±100 mM) for 4 h and, in other
experiments, with several concentrations of IL-
1b (0.1±10 ng/ml) or TNF-a (0.1±10 ng/ml) in
the presence or absence of dexamethasone
(10 mM) during 4 h. At the end of the incuba-
tion time, the supernatant was harvested as
described above.
Radioimmunoass ay to TXB2
TXB2 in macrophage supernatants was deter-
mined by radioimmunoassay (RIA) as pre-
viously described by Fuller et al.16 Brie￿y,
50 ml of standard TXB2 (or unknown samples)
and 50 ml of [3H]TXB2 were incubated with
50 ml of diluted antiserum to TXB2 overnight
at 48 C. Bound radioactivity was separated from
free radioactivity by addition of 1 ml of dex-
tran coated charcoal and centrifugation at
2800 rpm 48 C 20 min. The supernatants were
transferred to vials and diluted in 1 ml of
scintillation cocktail. A calibration curve was
established with standard TXB2 in a range
from 1 to 250 pg/0.1 ml. Assays were run in
duplicate. The level of sensitivity was
4 pg/0.1ml. The anti-TXB2 serum cross-reacted
0.5% PGF2a and was less than 0.1% PGF1a,
PGD 2, PGE1, 6-keto PGF1a. Results obtained in
the RIAs are expressed as picograms of TXB2
released per 105 macrophages or as the per-
centage of the maximum TXB2 released in
each experiment.
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Data are presented as the mean SEM. Statisti-
cal analysis was performed by unpaired Stu-
dent’s t-test (for two groups) or ANOVA (for
multiple comparisons). Differences between
values were considered signi￿cant if P, 0·05.
Results
TXB2 production induced by OZ,
IL-1b and TNF-a
The concentration and time-dependent effect of
OZ is shown in Fig. 1. Guinea-pig alveolar
macrophages incubated with OZ (0.01±
1 mg/ml) showed an enhanced production of
TXB2. This increase was signi￿cant after both 1
and 4 h of incubation, and the amount of
unstimulated and stimulated TXB2 was greater
after 4 h than after 1 h (P, 0·01). In both
cases, the maximum increase obtained in this
study was with 1 mg/ml of OZ. Cells exposed
to this concentration, for 4 h, released 258·6
15·0 pg of TXB2/105 cells.
The effect of the incubation with IL-1b (0.1±
10 ng/ml) and TNF-a (0.1±10 ng/ml), for 4 h,
on the production of TXB2 is shown in Fig. 2.
There was a small, but signi￿cant (P, 0·05),
concentration-dependent increase on the media-
tor release after 4 h, but not after 1 h (T able 1)
of incubation with both cytokines. IL-1b and
TNF-a induced a similar level of stimulation.
The maximum increase was also similar:
109·3 19·0 pg/105 cells to 3 ng/ml of IL-1b,
and 118·8 14·3 pg/105 cells to 3 ng/ml of
TNF-a. This value was lower than that induced
by OZ.
Effect of dexamethasone on the
zymosan-induced release
In Fig. 3, the incubation with dexamethasone
(10 mM) for 4 h did not alter the concentration
response to zymosan (0.01±1 mg/ml), although
it signi￿cantly (P, 0·05) reduced the unstimu-
lated release of TXB2. Fig. 4 shows that the
preincubation for 24 h (P, 0·01), but not 4 h,
with dexamethasone (0.1±100 mM) inhibited
TXB2 release induced by OZ(1 mg/ml).
Effect of dexamethasone on the IL-1b
or TNF-a release
The effect of the joint incubation with dexa-
methasone and IL-1b or TNF-a, for 4 h, is shown
in Fig. 5. When dexamethasone (0.1±100 mM)
was added with a ￿xed concentration of IL-1b
(1 ng/ml) or TNF-a (3 ng/ml), concentration
dependent inhibition of TXB2 release was ob-
served, and this was signi￿cant (P, 0·05) up to
1 mM to IL-1b and (P, 0·01) up to 10 mM to
TNF-a (Fig. 5A). The incubation with a ￿xed
high concentration of dexamethasone (10 mM)
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FIG. 1. TXB2 production induced by opsonized zymosan
(0.01±1 mg/ml), for 1 h (® lled circles) or 4 h (open circles),
from guinea-pig alveolar macrophages. P , 0.01, com-
pared with the results obtained after 1 h of incubation.
n > 6.
* * *
²
²
²
²
²
0 0.1 0.3 1 3 10 30
Cytokine (ng/ml)
0
50
100
150
T
X
B
2
 
(
p
g
/
1
0
5
 
c
e
l
u
l
a
s
)
FIG. 2. TXB2 production induced by IL-1b (0.1±10 ng/ml)
(open squares) or TNF-a (0.1±10 ng/ml) (open diamonds),
for 4 h, from guinea-pig alveolar macrophages. Asterisks
indicate the statistical signi® cance to IL-1b and daggers to
TNF-a. P , 0.05, †P , 0.05, compared with the control (0).
n > 6.
Table 1. The effect of the incubation with cytokines for 1 h
Addition TXB2 (pg/105 cells)
Control 9.2 2.5
IL-1b (ng/ml)
0.3 9.7 2.7
1 9.0 2.3
3 10.0 2.5
10 16.0 5.8
TNF-a (ng/ml)
3 9.7 3.0
10 10.4 1.7
None of the values is signi® cant compared with control. n > 5.
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Dexamethasone response depends on stimulisigni￿cantly (P, 0·05) inhibited both unstimu-
lated TXB2 and the concentration response to
IL-1b (0.1±10 ng/ml) or TNF-a (0.1±10 ng/ml)
(Fig. 5B).
Discussion
Incubation of guinea-pig alveolar macrophages
with IL-1b, TNF-a and OZ increase the release
of TXB2. However, this release has a different
time course and magnitude of effects. OZ
caused a more rapid and greater release of TXB2
either of the cytokines. A difference was also
found in the effects of dexamethasone on the
release induced by OZ and cytokines. Incuba-
tion with dexamethasone, for 4 h, reduced the
unstimulated TXB2 release in all studies and the
cytokines induced increase in release. No effect
after 4 h incubation was obtained on the in-
crease induced by OZ even at lower concentra-
tions. However, after 24 h incubation the effect
of OZ was reduced in a concentration depen-
dent fashion by dexamethasone.
The effects of the three stimuli used here
have been previously studied in other in￿amma-
tory cells. Opsonized zymosan induces the
eicosanoid release from rat peritoneal
leukocytes,17 human monocytes15 and human
macrophages16 after 1 h of incubation and these
results are consistent with our observations on
guinea-pig alveolar macrophages. The elimina-
tion of pathogens from human airways is
dependent to a great extent on the capacity of
resident macrophages to phagocytose, kill and
￿nally digest bacteria. Phagocytosis of OZ
rapidly activates macrophages to release numer-
ous lysosomal hydrolases, oxygen radicals and
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FIG. 3. The effect of the incubation with opsonized zymosan
(0.01±1 mg/ml) in the absence (open circles) or presence
(® lled circles) of dexamethasone (10 mM), for 4 h, on the
TXB2 release. P , 0.05, compared with the control. n > 6.
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FIG. 4. The effect of the preincubation with dexamethasone
(0.1±100mM), for 4 h (® lled circles) or 24 h (open circles), on
the TXB2 release induced by the further incubation, for 1 h,
with opsonized zymosan (1 mg/ml). P , 0.01, compared
with the control (100% = release induced by 1 mg/ml of
opsonized zymosan). n > 6.
*
**
**
‡
‡
0 0.1 1 10 100 1000
Dexamethasone (mM)
0
25
50
75
100
125
T
X
B
2
 
r
e
l
e
a
s
e
 
(
%
)
A
²
² ²
‡
* * * *
B
0 0.1 1 10 100
Cytokine (ng/ml)
0
50
100
150
T
X
B
2
 
(
p
g
/
1
0
5
 
c
e
l
l
s
)
FIG. 5. The effect of the joint incubation with dexamethasone and IL-1b (squares) or TNF-a (diamonds), for 4 h, on the TXB2
release. Asterisks indicate the statistical signi® cance to IL-1b and daggers to TNF-a. In (A) cells were incubated with a ® xed
dose of IL-1b (1 ng/ml) or TNF-a (3 ng/ml) in the absence (0) or presence of several doses of dexamethasone (0.1±100mM).
P , 0.05, P , 0.01, ‡P , 0.01, compared with the control (100%). n > 6. In (B) cells were incubated with several doses of
IL-1b (0.1±10 ng/ml) or TNF-a (0.1±10 ng/ml) in the absence (open symbols) or presence (® lled symbols) of a ® xed dose of
dexamethasone (10 mM). P , 0.05, P , 0.01, †P , 0.05, ‡P , 0.01, compared with the results obtained in the absence of
dexamethasone. n > 6.
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reproducing partially the response to infective
stimuli.24 In our experiments, IL-1b and TNF-a
also activate the TXB2 release from guinea-pig
alveolar macrophages but their effect is less
pronounced and delayed compared with the
one obtained with OZ. The results are consis-
tent with studies in other in￿ammatory cells,
where an increase on the eicosanoid release
induced by IL-1b and TNF-a has been
shown.3,5- 7 This effect requires long periods of
time to appear, beginning after 4 h and reaching
the maximum response after 12±24 h, depend-
ing on the type of cell, thus suggesting that it
could be mediated by an increase of the
synthesis of proteins. The incubation with
cycloheximide and actinomycin D abolish the
release of PGE2 induced by IL-1b from human
￿broblasts.10 Many cytokines, including IL-1b
and TNF-a activate the transcription factors AP-
1 and NFkB which regulate the gene transcrip-
tion of many target genes, including enzymes,
receptors and cytokines themselves13 and the
incubation with cytokines induces the produc-
tion of some enzymes involved in the phospho-
lipid breakdown. The increase of the
production of cPLA2,9 sPLA2 group II8,21 and
COX-211,12 induced by IL-1b and TNF-a has been
described in other in￿ammatory cells. These
enzymes could be responsible for the increase
of TXB2 induced by cytokines observed in our
experiments. However, whether or not the
production of cPLA2, sPLA2 group II and COX-2,
is mediated by the activation of AP-1 or NFkB
has not yet been established.
In guinea-pig alveolar macrophages, dexa-
methasone inhibits the TXB2 release induced by
OZ or cytokines, but the time course of this
response is different depending on the stimulus.
T o explain the reduction of mediators derived
from arachidonic acid induced by glucocortico-
steroids, mechanisms such as gene binding and
increase of lipocortins have been proposed.
Although lipocortin-1 inhibits the eicosanoid
release from rat and human macrophages,20
some authors have been unable to demonstrate
induction of lipocortins to explain the reduc-
tion of the eicosanoids induced by glucocortico-
steroids.18,25 In PM A-differentiated U937 cells
the incubation with dexamethasone for 16 h,
but not 4 h, caused an increase on the mRNA
level of lipocortin-1 and 2.26 This time course is
similar to the one found in our experiments on
the TXB2 release induced by OZ and this could
be the mechanism involved in the delayed effect
of dexamethasone. However, 4 h of incubation
with dexamethasone inhibits the TXB2 release
induced by IL-1b or TNF-a and the mechanism
involved in this effect could be different from
that observed in the release induced by OZ. In
several experimental models, glucocorticoster-
oids and cytokines have shown opposite effects
on the synthesis of proteins.14 Dexamethasone
inhibits the AP-1 and NFkB DNA binding in-
duced by IL-1b or TNF-a in human peripheral
blood mononuclear cells27 and combined treat-
ment with dexamethasone and TNF-a prevent
the increase in both AP-1 and NFkBbinding due
to TNF-a in human lung.28 Glucocorticosteroids
also prevent the activation of speci￿c enzymes
involved in the eicosanoid synthesis induced by
cytokines. Dexamethasone blocks the increase
in cPLA2,9 sPLA2 group II21 and COX-223,29
mediated by cytokines. A speci￿c interaction
between cytokines and glucocorticosteroids
could explain the rapid inhibitory effect of
dexamethasone on the TXB2 release induced by
IL-1b or TNF-a found in our experiments. How-
ever, high concentrations of dexamethasone
also inhibit the basal TXB2 release after 4 h of
incubation. This effect could be related to a
more rapid effect of dexamethasone at lower
levels of stimulation or to the increase of sPLA2
group II described after the culture of macro-
phages.30
In conclusion, we have found a different time
course on the effect of dexamethasone depend-
ing on the stimulus. Basal mediator release and
that induced by cytokines are rapidly prevented
by dexamethasone and this effect could be
mediated by the inhibition of transcription
factors or enzymes activated during the in￿am-
mation. However, the mediator release induced
by phagocytic stimuli requires longer incubation
for reduction by dexamethasone and this effect
could be due to a longer mechanism, such as
gene binding or release of lipocortins. These
results support the observation that glucocorti-
costeroids may not have an exclusive mechan-
ism to reduce the release of mediators derived
from arachidonic acid.
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